From clever drug formulation feasibility to tech transfer, we design formulations that balance pharmacokinetic properties, scalability, cost, compliance, and IP — so your program moves quick and de-risks diligence.
What “strategy” means at Callan Pharma Services
Unlike big-box CRO excipient screenings, our approach maps drug physiochemical constraints → delivery route → CMC risks → IP considerations into a streamlined plan with quick decision gates.
You get a balance of:
Pharmacology
Cost of Goods
Regulatory Compliance
Intellectual Property
Manufacturing
Typical Problems we solve (quickly)
How we work
Quick & clever
Small, fast screens with clear stop/go criteria. We avoid dwelling on formulation approaches with low potential.
IP-focused from day 1
We start a project with white-space analysis before we mix chemicals. If it’s not patentable, it’s not viable.
Partner, not vendor
Founder-level attention for all clients. Constant contact to furnish a collaborate development program.
Dogma-free approach
We have no loyalty to any excipient or platform. We search for the right solution, regardless of where it take us.
FAQs
What’s different about your strategy?
We start with IP outcomes in mind, then design quick formulation screenings to unlock further paths. All lead formulations are pressure tested for scaling up—filtration, hold times, temperature, etc.
What types of routes of administration do you work on?
We specialize in ophthalmic and all injectables.
Can you work on a project or FTE-basis?
Fractional FTE, project based, not-to-exceed, whatever is right for your project and budget.
How quickly can we begin lab work?
Most projects kick off within 1–2 weeks after the project is initiated.
Partner with Callan Pharma
Callan Pharma provides its partners rapid, comprehensive and cost-effective solutions for their difficult formulation development projects.
